Efficacy and Safety of Liposomal Bupivacaine Under ERAS Concept for Postoperative Analgesia of Ultrasound-Guided QLB in Gynecologic Laparoscopic Patients: A Randomized, Single-blind, Active-Controlled Clinical Study

Pharmacological Action Clinical Trial

Official title:
Efficacy and Safety of Liposomal Bupivacaine Under ERAS Concept for Postoperative Analgesia of Ultrasound-Guided QLB in Gynecologic Laparoscopic Patients: A Randomized, Single-blind, Active-Controlled Clinical Study

Status Recruiting

Clinical Trial Summary

With the development of the concept of comfortable medicine and enhanced recovery surgery (ERAS), optimizing the perioperative management of patients, reducing surgical stress, and reducing postoperative pain can effectively reduce perioperative complications and achieve the purpose of accelerating recovery. As an important part of ERAS, multimodal analgesia is the core concept of perioperative analgesia management. As a kind of perioperative multimodal analgesia, quadratus lumbar muscle block (QLB) is a type of local anesthetic drug injected around the quadratus lumbar muscle to reduce or eliminate abdominal wall pain and visceral pain after abdominal surgery. QLB has been used successfully for pain control after laparoscopic and open surgery, reducing perioperative opioid use and improving prognosis-related measures such as PONV and length of hospital stay. Bupivacaine liposomes use DepoFoam technology to encapsulate the drug in polycystic liposomes, which can prolong the release time of bupivacaine due to the different rupture times of different vesicles, and the postoperative analgesia can be up to 72 hours. In this project, patients who undergo elective laparoscopic uterine and double adnexectomy were selected to be injected with lipososomes of bupivacaine at different concentrations under ultrasound guidance of bilateral posterior QLB before anesthesia induction, and the effect of liposomal bupivacaine on postoperative pain was investigated by evaluating the postoperative pain and incidence of adverse events. This study will greatly promote the clinical promotion and application of bupivacaine liposome, improve the postoperative comfort and satisfaction of patients, and accelerate the postoperative recovery of patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Pharmacological Action

Clinical Trial Details

NCT number	NCT06288841
Study type	Interventional
Source	Tianjin Medical University General Hospital
Contact	Ning Luo
Phone	13622098703
Email	ningluo1996@163.com
Status	Recruiting
Phase	N/A
Start date	November 30, 2023
Completion date	November 29, 2024

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06040853` - Postoperative Pain in Laparoscopic Radical Prostatectomy Surgery With Tranexamic Acid: Analgesia? Hiperalgesia?	Phase 4
Not yet recruiting	`NCT05553496` - Assessment of Rituximab Therapeutic Response Versus Conventional Treatment	Phase 2/Phase 3
Recruiting	`NCT05534802` - Ulinastatin Improves and Prevents Cardiac Dysfunction Induced by Cardiopulmonary Bypass	N/A
Recruiting	`NCT04190537` - PARADOX - the Incidence of Paradoxical Reactions in Pediatric Patients Premedicated With Midazolam
Completed	`NCT03119454` - "Corticoid-16" in Long Term When Administered Systemically in Patients in Routine Medical Practice	N/A
Completed	`NCT03522532` - Dental Restorations Effect on Oxidative Status of the Gingival Crevicular Fluid	N/A
Unknown status	`NCT01614353` - Medication-taking Preferences & Practices of Patients With Chronic Conditions	N/A
Completed	`NCT03714360` - The Effect of Tranexamic Acid. A Randomised Study of Patients Undergoing Elective Lumbar Spine Surgery.	Phase 4
Recruiting	`NCT03352622` - Pharmacogenomic in Colombian Patients With Rheumatoid Arthritis	N/A
Not yet recruiting	`NCT04320277` - Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.	Phase 2/Phase 3
Completed	`NCT03359590` - Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes Patients	Phase 2
Completed	`NCT05591105` - Morphine Consumption in the Obese Patients
Not yet recruiting	`NCT03904303` - Test of a New Gel-based Colon Cleansing Agent Compared to Moviprep	Phase 1
Not yet recruiting	`NCT05453045` - Pharmacokinetics and Excretion of Albendazole and Its Metabolites in Saliva	N/A
Completed	`NCT05428683` - Intravitreal Triamcinolone and Moxifloxacin Injection After Cataract Surgery	N/A
Enrolling by invitation	`NCT02985281` - Safety and Efficacy of Gratisovir (Sofosbuvir)- Ribavirin Therapy in Pediatric Patients	Phase 2/Phase 3
Recruiting	`NCT06222710` - Ultrasound Guiding Pharmacopuncture Therapy for Supraspinatus Tendinopathy	N/A
Not yet recruiting	`NCT03953287` - Pharmacokinetic Study of Paracetamol.	Phase 1
Recruiting	`NCT03622047` - Comparison of Epidural Labor Analgesia With Dexmedetomidine or Sufentanil	N/A
Active, not recruiting	`NCT06324370` - Exploratory Pharmacokinetic Study of Virgin Coconut Oil (VCO)	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.